Snapshot from Aug 23, 2026 at 07:00 UTC. For live data and tracking: View Live
Business marketing agreement

Rocket Doctor AI retains B2i Digital

Analysis based on 7 articles · First reported Aug 05, 2026 · Last updated Aug 05, 2026

Sentiment
10
Attention
0
Articles
7
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The agreement is a minor corporate development for Rocket Doctor AI, Inc., potentially increasing its visibility among retail and institutional investors through B2i Digital's network of over 1.7 million market participants. The financial impact is limited to a modest cash fee, and the stock price impact is expected to be minimal.

Healthcare Marketing Services

Rocket Doctor AI, Inc. Inc., a Vancouver-based healthcare technology company listed on the Canadian Securities Exchange, entered into a digital advisory agreement with B2i Digital, Inc., a New York-based digital marketing firm. Under the agreement, B2i Digital will provide investor-focused marketing services including a featured company profile, paid advertising, content creation, social media distribution, email campaigns, and conference connections. The initial term is three months, with an option to extend to six or twelve months. Rocket Doctor AI, Inc. will pay B2i Digital a cash fee of $21,375 USD upon commencement, with additional fees for extensions. The agreement is subject to approval by the Canadian Securities Exchange. The collaboration aims to broaden Rocket Doctor AI, Inc.'s presence in the United States, particularly in New York, and to promote its AI-powered healthcare solutions.

priv
Rocket Doctor AI, Inc. is the primary party, entering into a marketing agreement to enhance its investor visibility and expand its US presence. The agreement is a strategic move to increase awareness of its AI healthcare platform.
Importance 100.0 Sentiment 10.0
per
Essam Hamza, CEO of Rocket Doctor AI, Inc., is a key figure in the agreement, expressing enthusiasm for the collaboration and its potential to broaden the company's US presence.
Importance 40.0 Sentiment 10.0
per
David Shapiro, CEO of B2i Digital, is instrumental in selecting Rocket Doctor AI, Inc. as a featured company and will oversee the marketing services. His endorsement adds credibility to the agreement.
Importance 40.0 Sentiment 10.0
exch
The Canadian Securities Exchange is the regulatory body whose approval is required for the agreement. Its role is administrative and does not directly affect its operations.
Importance 20.0 Sentiment 0.0
cnt
The United States is the target market for Rocket Doctor AI, Inc.'s expansion, with the agreement aimed at increasing its presence there, particularly in New York.
Importance 20.0 Sentiment 0.0
loc
United States — New York City is the base of B2i Digital and a key focus for Rocket Doctor AI, Inc.'s US expansion, as highlighted by the CEO's comments.
Importance 20.0 Sentiment 0.0
per
William Cherniak, CEO of Rocket Doctor AI, Inc., is mentioned as a contact but has no direct role in the agreement.
Importance 10.0 Sentiment 0.0
cnt
Canada is the home country of Rocket Doctor AI, Inc. and Rocket Doctor AI, Inc., and the agreement is subject to Canadian securities regulations.
Importance 10.0 Sentiment 0.0
United States trade rivals Canada The United States views Canada as a key defense partner but also a trade rival, having imposed tariffs and declined to r
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.